Celldex Therapeutics, Inc. — Director's Dealing 2015

Nov 25, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Celldex Therapeutics, Inc. (CLDX)
CIK: 0000744218
Period of Report: 2015-11-23

Reporting Person: CATLIN AVERY W (Sr. VP & CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-11-23	Common Stock	M	25000	$8.52	Acquired	60109	Direct
2015-11-23	Common Stock	S	25000	$18	Disposed	35109	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-23	Non-Qualified Stock Option	$8.52	M	25000	Disposed	2019-01-06	Common Stock (25000)	Direct

Footnotes

F1: The sale reported on this Form 4 was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2015. The options exercised and sold by the Reporting Person were due to expire January 6, 2019.

F2: As of January 6, 2013, the option is fully vested.